Prenatal exposure to systemic antibacterials and overweight and obesity in Danish schoolchildren: a prevalence study

A Mor1, S Antonsen1, J Kahlert1

  • 1Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.

Insights

Prenatal exposure to antibacterials is linked to a higher risk of overweight and obesity in children. This association was observed in schoolchildren and varied based on birth weight.

Area of Science:

  • Reproductive Health
  • Pediatric Health
  • Metabolic Disorders

Background:

  • Prenatal exposure to antibacterials may impact fetal development through epigenetic changes or altered maternal microbiota.
  • Systemic antibacterial use during pregnancy raises concerns about long-term metabolic health in offspring.

Purpose of the Study:

  • To investigate the association between prenatal exposure to systemic antibacterials and the risk of overweight and obesity in schoolchildren.
  • To explore how birth weight modifies this association.

Main Methods:

  • A prevalence study utilizing data from Danish schoolchildren aged 7-16 years (2002-2013).
  • Prenatal antibacterial exposure was identified through maternal prescription records and infection-related hospitalizations.
  • Overweight and obesity were defined using standard age- and sex-specific criteria; analyses were adjusted for covariates and stratified by birth weight.

Main Results:

  • Prenatal antibacterial exposure was associated with increased prevalence ratios for overweight (1.26) and obesity (1.29) in schoolchildren.
  • Associations differed between sexes and were influenced by birth weight, with distinct patterns for overweight and obesity relative to birth weight thresholds.

Conclusions:

  • Prenatal exposure to systemic antibacterials is associated with an elevated risk of overweight and obesity in school-aged children.
  • The relationship between prenatal antibacterial exposure and childhood overweight/obesity is moderated by birth weight.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
343
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
38
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
38
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
394
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K